Moving Forward on Clinical Trial Diversity: Insights from Our Stakeholder Workshop
In June 2021, 500+ health care and community members from over 150 organizations came together at PhRMA’s first stakeholder workshop focused on improving diversity in clinical trials. Take a look at the highlights from the in-depth conversations.

Enhancing clinical trial diversity: Stakeholder perspectives on advancing research through representative clinical trials, covers key barriers and potential solutions to improving clinical trial diversity. This research is an important step in the industry’s broader effort to address disparities within the U.S. health care system.

As we endeavor to push forward to change the future, we must first understand the past. Colonization, slavery, segregation, systemic racism—these experiences continue to disproportionately impact underserved communities and have created a foundation of mistrust rooted in history.
*This publication offers a limited number of free article views per month and then requires a subscription
Here is a small sampling of formative events in U.S. history that have shaped the relationship communities of color have with medical research and the health care system. This list is by no means exhaustive, but we hope it helps pave the way for candid dialogue that guides our work on equity.
Slavery
Gynecological Experimentation on Enslaved Women
Closing of Medical Schools and Exclusion of Future Health Providers
Birth Control Experimentation in Puerto Rico
The Tuskegee Syphilis Study
Henrietta Lacks
Radioactive Iodine
Slavery (1619 - 1865)

Gynecological Experimentation On Enslaved Women (1845 - 1849)

Closing Of Medical Schools and Exclusion Of Future Health Providers (1870)

Birth Control Experimentation in Puerto Rico (1930s - 1970s)

The Tuskegee Syphilis Study (1932 - 1972)

Henrietta Lacks (1951)

Radioactive iodine (1956 - 1957)

What We Do Matters; How We Do It Is Equally Important
A conversation on why a community-centric approach is needed to build trust, increase awareness, enhance clinical trial diversity and advance health equity.
Voices from Our Blog




























The FDA’s Office of Minority Health and Health Equity (OMHHE) was established in 2010 with the mission of protecting and promoting the health of racial and ethnic minority and other diverse populations...








The FDA’s Office of Minority Health and Health Equity (OMHHE) was established in 2010 with the mission of protecting and promoting the health of racial and ethnic minority and other diverse populations...























